1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow Bio89-100: new trials by email Literature Review of Bio89-100 trials Research Report on Bio89-100
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis) Pegozafermin, Placebo - Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | Phase 3 | Recruiting | Hoffmann-La Roche | 1350 | 2024-03-13 | 2026-10-23 |
Digestive System Diseases (1) · Fatty Liver (1) · Fibrosis (1) · Liver Diseases (1) · Metabolic Diseases (1) · Non-alcoholic Fatty Liver Disease (1)
Argentina (1) · Australia (1) · Austria (1) · Belgium (1) · Bulgaria (1) · Canada (1) · Czechia (1) · France (1) · Georgia (1) · Germany (1) · Hong Kong (1) · India (1) · Israel (1) · Italy (1) · Japan (1)